Valine mutation for both methionine oxidation sites of CaMKII reduces atrial fibrillation, similar to methionine sulfoxide reductase overexpression, indicating a pathological role for oxidized CaMKII in cardiac disease [39]. This evidence concerns the gene CAMK2G and atrial fibrillation.